Form 4: Abbott Laboratories Executive Vice President Daniel Gesua Sive Salvadori Reports Stock Transactions
SEC Form 4
Executive Vice President Daniel Gesua Sive Salvadori reports the disposition of Abbott Laboratories shares to cover tax obligations and a sale of shares on March 1, 2024.
Summary
- On February 29, 2024, Daniel Gesua Sive Salvadori, an Executive Vice President at Abbott Laboratories, disposed of 8,874 common shares to cover tax obligations at a price of $120.05.
- Following this transaction, Salvadori directly owned 126,660 common shares.
- On March 1, 2024, Salvadori sold 963 common shares at a price of $118.5, resulting in direct ownership of 125,697 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, and it doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice and required by the SEC.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Disposition of 8,874 common shares to cover tax obligations at $120.05 per share. |
| 03/01/2024 | Sale of 963 common shares at $118.5 per share. |
| 03/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.